Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2878574/0/en/Arecor-and-Medtronic-Diabetes-establish-collaboration-to-develop-a-novel-thermostable-insulin-for-implantable-pump-delivery.html
12 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/03/12/2844424/0/en/ARECOR-AND-TRx-BIOSCIENCES-ESTABLISH-RESEARCH-COLLABORATION-TO-DEVELOP-ORAL-GLP-1-WITH-ENHANCED-BIOAVAILABILITY.html
24 Jan 2024
// PRESS RELEASE
https://www.sanofi.com/en/media-room/press-releases/2024/2024-01-23-06-30-00-2813696
17 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/17/2782367/0/en/First-Product-Incorporating-Arecor-s-Arestat-Technology-At220-Launched-in-Europe.html
20 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/20/2708064/0/en/Arecor-Business-Update.html
11 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/11/2531637/0/en/Headline-results-from-Phase-I-clinical-trial-of-ultra-rapid-acting-insulin-candidate-AT247-demonstrate-significantly-accelerated-insulin-absorption-and-early-exposure-compared-to-g.html
ABOUT THIS PAGE